BAY1902607
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY1902607, covering 2021-02-10 to 2021-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients [Phase 1, Phase 2]